ANALYSIS OF THE PD-1/PD-L1 AXIS POINTS TO ASSOCIATION OF UNFAVORABLE RECURRENT MUTATIONS WITH PD-L1 EXPRESSION IN AML

被引：0

作者：

Giannopoulos, K. ^{[1
,2
]}

Zajac, M. ^{[1
]}

Zaleska, J. ^{[1
]}

Dolnik, A. ^{[3
]}

Siwiec, A. ^{[4
]}

Jankowska-Lecka, O. ^{[5
,6
]}

Mlak, R. ^{[7
]}

Ciesielka, M. ^{[8
]}

Gromek, T. ^{[5
,6
]}

Sokolowska, B. ^{[5
,6
]}

Grzasko, N. ^{[2
]}

Soroka-Wojtaszko, M. ^{[5
,6
]}

Szudy-Szczyrek, A. ^{[5
,6
]}

Majdan, M. ^{[4
]}

Hus, M. ^{[5
,6
]}

Bullinger, L. ^{[3
]}

机构：

[1] Med Univ Lublin, Expt Hematooncol Dept, Lublin, Poland

[2] St Johns Canc Ctr, Dept Hematol, Lublin, Poland

[3] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[4] Med Univ Lublin, Dept Rheumatol & Connect Tissue Dis, Lublin, Poland

[5] Med Univ Lublin, Dept Hematooncol, Lublin, Poland

[6] Med Univ Lublin, Bone Marrow Transplantat Unit, Lublin, Poland

[7] Med Univ Lublin, Dept Human Physiol, Lublin, Poland

[8] Med Univ Lublin, Dept Forens Med, Lublin, Poland

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E888

引用

页码：365 / 365

页数：1

共 50 条

[31] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Dimitrios Mathios
Jacob Ruzevick
Christopher M. Jackson
Haiying Xu
Sagar Shah
Janis M. Taube
Peter C. Burger
Edward F. McCarthy
Alfredo Quinones-Hinojosa
Drew M. Pardoll
Michael Lim
Journal of Neuro-Oncology, 2015, 121 : 251 - 259
[32] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Mathios, Dimitrios
Ruzevick, Jacob
Jackson, Christopher M.
Xu, Haiying
Shah, Sagar
Taube, Janis M.
Burger, Peter C.
McCarthy, Edward F.
Quinones-Hinojosa, Alfredo
Pardoll, Drew M.
Lim, Michael
JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
[33] PD-1 and PD-L1 prognostic in UTUC
Stone, Louise
NATURE REVIEWS UROLOGY, 2017, 14 (09) : 518 - 518
[34] PD-1 and PD-L1 prognostic in UTUC
Louise Stone
Nature Reviews Urology, 2017, 14 : 518 - 518
[35] A snapshot of the PD-1/PD-L1 pathway
Ghosh, Chinmoy
Luong, Gary
Sun, Yue
JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
[36] PD-1/PD-L1 in cardiovascular disease
Sun, YunFeng
Li, Liang
Wu, YaWei
Yang, KePing
CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30
[37] PD-1 and PD-L1 antibodies for melanoma
Tsai, Katy K.
Zarzoso, Ines
Daud, Adil I.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
[38] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Rosemarie Tremblay-LeMay
Nasrin Rastgoo
Hong Chang
Journal of Hematology & Oncology, 11
[39] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
Guo, Jiazheng
Yu, Fengyi
Zhang, Kuojun
Jiang, Sheng
Zhang, Xiangyu
Wang, Tianyu
RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
[40] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Tremblay-LeMay, Rosemarie
Rastgoo, Nasrin
Chang, Hong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11

← 1 2 3 4 5 →